New Delhi: The United States imports nearly 40 per cent of its generic medicines from India because of the confidence it has in the country’s pharmaceutical capabilities, US Ambassador to India H.E. Sergio Gor said in April, underlining the depth of trust that now characterises one of the world’s most consequential strategic partnerships.

Speaking at the Advancing Partnership in Research and Innovation event at the Indian Institute of Technology (IIT) Delhi, Ambassador Gor said the India-US relationship had expanded dramatically across sectors ranging from trade and defence to technology, healthcare and space cooperation.

Highlighting the critical role played by India in supporting American healthcare needs, the Ambassador said the US relies heavily on Indian pharmaceutical exports because of their quality and reliability. “On pharmaceuticals, we import close to 40 per cent of our generics from India. There is a reason the United States does that: it is because we trust India. These are critical life-saving ingredients that are needed in the United States,” he said.

Describing India-US relations as one of the defining partnerships of the 21st century, Ambassador Gor pointed to the remarkable growth in bilateral commerce over the past two decades. “In just over two decades, bilateral trade has grown from 20 billion dollars to over 220 billion dollars in goods and services. That’s not just volume; it reflects deeper, broader engagement and stronger economic integration,” he observed.

The Ambassador also expressed optimism regarding the proposed interim trade agreement currently under negotiation between the two countries. According to him, discussions have entered their final stages and could culminate in a formal agreement in the coming weeks or months. “Our current interim trade agreement is on the table for us to finalise that will unlock prosperity for both of our countries. We fully expect that the trade deal will be signed over the next few weeks and months,” he said.

The comments come at a time when economic ties between New Delhi and Washington continue to deepen, with trade, technology and investment emerging as major pillars of the bilateral relationship.

Ambassador Gor further highlighted the scale of American corporate investments flowing into India, particularly in technology and digital infrastructure. According to him, Amazon plans to invest US$35 billion in India by 2030 to support AI-driven digitisation, exports and job creation. Microsoft has announced investments of US$17.5 billion, including the expansion of hyperscale cloud infrastructure, while Google has initiated work on a subsea cable landing terminal project estimated at around US$15 billion. “These are incredible things that we have seen just from a handful of companies,” he said.

The Ambassador noted that business leaders and investors who engage with the US Embassy frequently seek reassurance about India’s attractiveness as an investment destination. “Many investors ask us whether India is a safe destination for investment and partnership. Our answer to them is yes,” he said.

His remarks reflected growing confidence among American businesses in India’s long-term economic prospects, strengthening the view that the India-US partnership is increasingly driven not only by strategic considerations but also by expanding commercial and technological cooperation.